Abstract

Clinical utility of magnetic resonance spectroscopy to enhance diagnosis of HIV-associated mild neurocognitive disorder

Karl Goodkin, Jeffry R Alger, Andrew A Maudsley, Varan Govind, Sulaiman Sheriff, Jingjing Michele Zhang

HIV-associated neurocognitive disorder (HAND) is currently prevalent at epidemic proportions within the HIV-infected patient population. Of the conditions identified as ‘HAND’, the milder conditions of mild neurocognitive disorder (MND) and asymptomatic neurocognitive impairment are more common than the severe condition of HIV-associated dementia in the current era of effective antiretroviral therapy (ART).